151 related articles for article (PubMed ID: 24029385)
1. Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage.
Nagano T; Higashisaka K; Kunieda A; Iwahara Y; Tanaka K; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Yoshioka Y; Tsutsumi Y
Nanotechnology; 2013 Oct; 24(40):405102. PubMed ID: 24029385
[TBL] [Abstract][Full Text] [Related]
2. Modifying the Surface of Silica Nanoparticles with Amino or Carboxyl Groups Decreases Their Cytotoxicity to Parenchymal Hepatocytes.
Nagano T; Nagano K; Nabeshi H; Yoshida T; Kamada H; Tsunoda SI; Gao JQ; Higashisaka K; Yoshioka Y; Tsutsumi Y
Biol Pharm Bull; 2017; 40(5):726-728. PubMed ID: 28458361
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum microRNAs as potential toxicological biomarkers for toosendanin-induced liver injury in mice.
Yang F; Li L; Yang R; Wei M; Sheng Y; Ji L
Phytomedicine; 2019 May; 58():152867. PubMed ID: 30844585
[TBL] [Abstract][Full Text] [Related]
4. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Kondoh M; Yagi K; Mayumi T; Tsunoda S; Tsutsumi Y
Nanotechnology; 2012 Feb; 23(4):045101. PubMed ID: 22214761
[TBL] [Abstract][Full Text] [Related]
5. A Performance Evaluation of Liver and Skeletal Muscle-Specific miRNAs in Rat Plasma to Detect Drug-Induced Injury.
Bailey WJ; Barnum JE; Erdos Z; LaFranco-Scheuch L; Lane P; Vlasakova K; Sistare FD; Glaab WE
Toxicol Sci; 2019 Mar; 168(1):110-125. PubMed ID: 30496518
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies.
Sharapova T; Devanarayan V; LeRoy B; Liguori MJ; Blomme E; Buck W; Maher J
Vet Pathol; 2016 Jan; 53(1):211-21. PubMed ID: 26123229
[TBL] [Abstract][Full Text] [Related]
7. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
Kagawa T; Shirai Y; Oda S; Yokoi T
Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity of silica nanoparticles with a diameter of 100 nm.
Hasezaki T; Isoda K; Kondoh M; Tsutsumi Y; Yagi K
Pharmazie; 2011 Sep; 66(9):698-703. PubMed ID: 22026127
[TBL] [Abstract][Full Text] [Related]
9. Studying the association of microRNA-210 level with chronic hepatitis B progression.
Song G; Jia H; Xu H; Liu W; Zhu H; Li S; Shi J; Li Z; He J; Chen Z
J Viral Hepat; 2014 Apr; 21(4):272-80. PubMed ID: 24597695
[TBL] [Abstract][Full Text] [Related]
10. Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice.
Yoshida T; Yoshioka Y; Morishita Y; Aoyama M; Tochigi S; Hirai T; Tanaka K; Nagano K; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Higashisaka K; Tsutsumi Y
Nanotechnology; 2015 Jun; 26(24):245101. PubMed ID: 26011124
[TBL] [Abstract][Full Text] [Related]
11. Effect of surface charge on nano-sized silica particles-induced liver injury.
Isoda K; Hasezaki T; Kondoh M; Tsutsumi Y; Yagi K
Pharmazie; 2011 Apr; 66(4):278-81. PubMed ID: 21612155
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.
Bala S; Petrasek J; Mundkur S; Catalano D; Levin I; Ward J; Alao H; Kodys K; Szabo G
Hepatology; 2012 Nov; 56(5):1946-57. PubMed ID: 22684891
[TBL] [Abstract][Full Text] [Related]
13. Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats.
Park HK; Jo W; Choi HJ; Jang S; Ryu JE; Lee HJ; Lee H; Kim H; Yu ES; Son WC
J Vet Sci; 2016 Mar; 17(1):45-51. PubMed ID: 27051339
[TBL] [Abstract][Full Text] [Related]
14. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
Krauskopf J; Caiment F; Claessen SM; Johnson KJ; Warner RL; Schomaker SJ; Burt DA; Aubrecht J; Kleinjans JC
Toxicol Sci; 2015 Feb; 143(2):268-76. PubMed ID: 25359176
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-122-3p, microRNA-194-5p and microRNA-5099 are potential toxicological biomarkers for the hepatotoxicity induced by Airpotato yam.
Yang R; Yang F; Huang Z; Jin Y; Sheng Y; Ji L
Toxicol Lett; 2017 Oct; 280():125-132. PubMed ID: 28844483
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-derived microRNAs as sensitive serum biomarkers of hepatocellular injury in Labrador retrievers.
Dirksen K; Verzijl T; van den Ingh TS; Vernooij JC; van der Laan LJ; Burgener IA; Spee B; Fieten H
Vet J; 2016 May; 211():75-81. PubMed ID: 27021912
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells.
Yoshida T; Yoshioka Y; Matsuyama K; Nakazato Y; Tochigi S; Hirai T; Kondoh S; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Tsutsumi Y
Biochem Biophys Res Commun; 2012 Nov; 427(4):748-52. PubMed ID: 23044420
[TBL] [Abstract][Full Text] [Related]
18. Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials.
Higashisaka K; Yoshioka Y; Yamashita K; Morishita Y; Fujimura M; Nabeshi H; Nagano K; Abe Y; Kamada H; Tsunoda S; Yoshikawa T; Itoh N; Tsutsumi Y
Biomaterials; 2011 Jan; 32(1):3-9. PubMed ID: 20864168
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-122, -21 and -223 as potential markers of liver injury following warm ischaemia and reperfusion in rats.
Van Caster P; Brandenburger T; Strahl T; Metzger S; Bauer I; Pannen B; Braun S
Mol Med Rep; 2015 Aug; 12(2):3146-50. PubMed ID: 25954995
[TBL] [Abstract][Full Text] [Related]
20. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.
Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL
Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
